Untitled

HealthTrust presents…”Has Phenobarbital Got It All? The Role of  Phenobarbital in Alcohol Withdrawal Syndrome”

Benzodiazepines (BZDs) are generally considered the mainstay of treatment for alcohol withdrawal syndrome (AWS). In recent years, interest has grown in investigating if BZDs are superior to other agents, such as phenobarbital. Previous studies have suggested the potential for reduced intensive care unit admission and mechanical ventilation with use of phenobarbital for AWS. While literature exists showing positive clinical outcomes when using phenobarbital, pharmacists and clinicians may not be as familiar with using phenobarbital in AWS due to more clinical experience with the use of BZDs. This session will provide comprehensive education on the role of phenobarbital in AWS so that the attendee gains confidence in recommending the best course of treatment relative to the patient.

Learning Objectives for Pharmacists & Nurses   |  At the end of this session, participants should be able to:

1. Identify phenobarbital dosing, monitoring for clinical efficacy, and side effects when used in alcohol withdrawal syndrome (AWS)
2. Recall findings from recent clinical research on the role of phenobarbital in AWS
3. Recognize appropriate recommendations for the use of phenobarbital in AWS and opportunities for integration into institutional protocols

Presenter:

Jesse Lewandowski, PharmD, PGY-2 Emergency Medicine Pharmacy Resident  |  Robert Wood Johnson University Hospital  |  New Brunswick, NJ

Target Audience: Pharmacists & Nurses

CE Credit: Approved for Nurses, pending for Pharmacists

This program is pending approval for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is pending. The activity is pending approval for 1 hour (.1 CEUs) of continuing education credit for Pharmacists and approved for Nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.